|| C. Papagoras, P. V. Voulgari, and A. A. Drosos, "Strategies after the failure of the first anti-tumor necrosis factor alpha agent in rheumatoid arthritis," Autoimmunity Reviews, vol. 9, pp. 574-582, 2010.|
 Z. Huang, Z. Zhang, Y. Zha, J. Liu, Y. Jiang, Y. Yang, J. Shao, X. Sun, X. Cai, Y. Yin, J. Chen, L. Dong, and J. Zhang, "The effect of targeted delivery of anti-TNF-α oligonucleotide into CD169+ macrophages on disease progression in lupus-prone MRL/lpr mice," Biomaterials, vol. 33, pp. 7605-7612, 2012.
 J. Maria, S. Karin, R. Cecilia, M. Brian, K. Søren, N. D. Tomas, G. J. Thomas, and G. M. Jacob, "Amelioration of Psoriasis by Anti-TNF-α RNAi in the Xenograft Transplantation Model′," Molecular Therapy, vol. 17, pp. 1743-53, 2009.
 M. L. Moss, L. Sklair-Tavron, and R. Nudelman, "Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis," Nature Clinical Practice Rheumatology, vol. 4, pp. 300-309, 2008.
 R. C. Newton, K. A. Solomon, M. B. Covington, C. P. Decicco, P. J. Haley, S. M. Friedman, and K. Vaddi, "Biology of TACE inhibition," Annals of the Rheumatic Diseases, vol. 60, pp. III25-III32, 2001.
 P. D. Robbins and S. C. Ghivizzani, "Viral vectors for gene therapy," Pharmacology & Therapeutics, vol. 80, pp. 35-47, 1998.
 M. S. Al-Dosari and X. Gao, "Nonviral Gene Delivery: Principle, Limitations, and Recent Progress," Aaps Journal, vol. 11, pp. 671-681, 2009.
 J. L. Santos, D. Pandita, J. Rodrigues, A. P. Pego, P. L. Granja, and H. Tomas, "Non-Viral Gene Delivery to Mesenchymal Stem Cells: Methods, Strategies and Application in Bone Tissue Engineering and Regeneration," Current Gene Therapy, vol. 11, pp. 46-57, 2011.
 C. Ortiz Mellet, J. M. Garcia Fernandez, and J. M. Benito, "Cyclodextrin-based gene delivery systems," Chemical Society Reviews, vol. 40, pp. 1586–1608, 2011.
 M. A. Mintzer and E. E. Simanek, "Nonviral Vectors for Gene Delivery," Chemical Reviews, vol. 109, pp. 259-302, 2009.
 N. A. Alhakamy and C. J. Berkland, "Polyarginine molecular weight determines transfection efficiency of calcium condensed complexes," Mol Pharm, vol. 10, pp. 1940-8, 2013.
 S. Futaki, S. Goto, and Y. Sugiura, "Membrane permeability commonly shared among arginine-rich peptides," Molecular Recognition, vol. 16, pp. 260-264, 2003.
 S. Futaki, I. Nakase, A. Tadokoro, T. Takeuchi, and A. T. Jones, "Arginine-rich peptides and their internalization mechanisms," Biochemical Society Transactions, vol. 35, pp. 784-787, 2007.
 H. D. Herce, A. E. Garcia, J. Litt, R. S. Kane, P. Martin, N. Enrique, A. Rebolledo, and V. Milesi, "Arginine-Rich Peptides Destabilize the Plasma Membrane, Consistent with a Pore Formation Translocation Mechanism of Cell-Penetrating Peptides," Biophysical Journal, vol. 97, pp. 1917-1925, 2009.
 D. J. Mitchell, D. T. Kim, L. Steinman, C. G. Fathman, and J. B. Rothbard, "Polyarginine enters cells more efficiently than other polycationic homopolymers," J Pept Res, vol. 56, pp. 318-325, 2000.
 S. H. Lee, B. Castagner, and J. C. Leroux, "Is there a future for cell-penetrating peptides in oligonucleotide delivery?," Eur J Pharm Biopharm, vol. 85, pp. 5-11, 2013.
 R. Breslow, S. Belvedere, L. Gershell, and D. Leung, "The chelate effect in binding, catalysis, and chemotherapy," Pure and Applied Chemistry, vol. 72, pp. 333-342, 2000.
 W.-w. H. Chiao-chun Yeh, "The use of short peptides conjugated PEI for gene delivery application," 2013.
 W. W. Hu, Z. W. Lin, R. C. Ruaan, W. Y. Chen, S. L. C. Jin, and Y. Chang, "A novel application of indolicidin for gene delivery," International Journal of Pharmaceutics, vol. 456, pp. 293-300, 2013.
 A. K. Abbas, A. H. H. Lichtman, and S. Pillai, Basic Immunology: Functions and Disorders of the Immune System: Elsevier Health Sciences, 2012.
 M. Srirupa, R. H. John, and K. M. Tapan, "Role of TNFα in pulmonary pathophysiology," Respiratory Research, vol. 7, pp. 1-9, 2006.
 O. L. Carswell EA, Kassel RL, Green S, Fiore N, Williamson B, "Anendotoxin-induced serum factor that causes necrosis of tumors. ," Proceedings of the National Academy of Sciences of the United States of America, pp. 3666-3670., 1975.
 M. R. Shalaby, B. B. Aggarwal, E. Rinderknecht, L. P. Svedersky, B. S. Finkle, and M. A. Palladino, "Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors," The Journal of Immunology, vol. 135, pp. 2069-2073, 1985.
 S. J. V. Deventer, "Tumour necrosis factor and Crohn′s disease," Gut, vol. 40, pp. 443-448, 1997.
 魏正宗, "抗腫瘤壞死因子製劑 (Anti-TNF)," 台灣醫界, vol. 第46卷, 2003.
 S. Tsiodras, G. Samonis, D. T. Boumpas, and D. P. Kontoyiannis, "Fungal infections complicating tumor necrosis factor alpha blockade therapy," Mayo Clinic Proceedings, vol. 83, pp. 181-194, 2008.
 D. o. Health, "Our inheritance, our future – realising the potential of genetics in the NHS. ," Genetics White Paper, vol. 1, p. 19, 2003.
 K. B. Kaufmann, H. Buning, A. Galy, A. Schambach, and M. Grez, "Gene therapy on the move," Embo Molecular Medicine, vol. 5, pp. 1642-1661, 2013.
 K. K. Jain, "Gene therapy," PHARMACOLOGY, vol. 2, 2007.
 L. K. Branski, C. T. Pereira, D. N. Herndon, and M. G. Jeschke, "Gene therapy in wound healing: present status and future directions," Gene Therapy, vol. 14, pp. 1-10, 2007.
 E. H. Kaji and J. M. Leiden, "Gene and stem cell therapies," Jama-Journal of the American Medical Association, vol. 285, pp. 545-550, 2001.
 E. Hood, "RNAi: what′s all the noise about gene silencing?," Environmental Health Perspectives, vol. 112, pp. A224-A229, 2004.
 G. W. Redberry, Gene silencing : new research. New York: Nova Science Publishers, 2006.
 V. K. Sharma, P. Rungta, and A. K. Prasad, "Nucleic acid therapeutics: basic concepts and recent developments," Rsc Advances, vol. 4, pp. 16618-16631, 2014.
 D. Grimm, "Small silencing RNAs: State-of-the-art," Advanced Drug Delivery Reviews, vol. 61, pp. 672-703, 2009.
 S. T. Crooke, "Progress in antisense technology," Annual Review of Medicine, vol. 55, pp. 61-95, 2004.
 N. Dias and C. A. Stein, "Antisense oligonucleotides: Basic concepts and mechanisms," Molecular Cancer Therapeutics, vol. 1, pp. 347-355, 2002.
 A. Forte, M. Cipollaro, A. Cascino, and U. Galderisi, "Small interfering RNAs and antisense oligonucleotides for treatment of neurological diseases," Current Drug Targets, vol. 6, pp. 21-29, 2005.
 陳一村, "核糖核酸干擾術及其應用," biomedicine, vol. 1, 2008.
 S. M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl, "Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells," Nature, vol. 411, pp. 494-498, 2001.
 S. Parrish, J. Fleenor, S. Q. Xu, C. Mello, and A. Fire, "Functional anatomy of a dsRNA trigger: Differential requirement for the two trigger strands in RNA interference," Molecular Cell, vol. 6, pp. 1077-1087, 2000.
 P. D. Zamore, T. Tuschl, P. A. Sharp, and D. P. Bartel, "RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals," Cell, vol. 101, pp. 25-33, 2000.
 D. P. Bartel, "MicroRNAs: Genomics, biogenesis, mechanism, and function," Cell, vol. 116, pp. 281-297, 2004.
 N. I. Khatri, M. N. Rathi, D. P. Baradia, S. Trehan, and A. R. Misra, "In Vivo Delivery Aspects of miRNA, shRNA and siRNA," Critical Reviews in Therapeutic Drug Carrier Systems, vol. 29, pp. 487-527, 2012.
 M. D. Emine, "Antisense Oligodeoxynucleotide Technology:A Novel Tool for Gene Silencing in Higher Plants " 2012.
 A. L. Jackson, J. Burchard, J. Schelter, B. N. Chau, M. Cleary, L. Lim, and P. S. Linsley, "Widespread siRNA "off-target′′ transcript silencing mediated by seed region sequence complementarity," Rna-a Publication of the Rna Society, vol. 12, pp. 1179-1187, 2006.
 J. Wang, Z. Lu, M. G. Wientjes, and J. L. S. Au, "Delivery of siRNA Therapeutics: Barriers and Carriers," Aaps Journal, vol. 12, pp. 492-503, 2010.
 L. Dong, S. H. Xia, Y. Luo, H. J. Diao, J. Zhang, J. N. Chen, and J. F. Zhang, "Targeting delivery oligonucleotide into macrophages by cationic polysaccharide from Bletilla striata successfully inhibited the expression of TNF-alpha," Journal of Controlled Release, vol. 134, pp. 214-220, 2009.
 J. Kurreck, "Antisense technologies. Improvement through novel chemical modifications," Eur J Biochem, vol. 270, pp. 1628-1644, 2003.
 G. Galietta, A. Loizzo, S. Loizzo, G. Trombetta, S. Spanipinato, G. Campana, A. Capasso, M. Palermo, I. Guarino, and F. Franconi, "Administration of antisense oligonucleotide against pro-opiomelanocortin prevents enduring hormonal alterations induced by neonatal handling in male mice," European Journal of Pharmacology, vol. 550, pp. 180-185, 2006.
 T. Blessing, J. S. Remy, and J. P. Behr, "Monomolecular collapse of plasmid DNA into stable virus-like particles," Proceedings of the National Academy of Sciences of the United States of America, vol. 95, pp. 1427-1431, 1998.
 D. Bouard, N. Alazard-Dany, and F. L. Cosset, "Viral vectors: from virology to transgene expression," British Journal of Pharmacology, vol. 157, pp. 153-165, 2009.
 A. D. Miller, D. G. Miller, J. V. Garcia, and C. M. Lynch, "Use of retroviral vectors for gene transfer and expression," Methods in Enzymology, vol. 217, pp. 581-599, 1993.
 E. Tomlinson and A. P. Rolland, "Controllable gene therapy - Pharmaceutics of non-viral gene delivery systems," Journal of Controlled Release, vol. 39, pp. 357-372, 1996.
 P. O. Eric, "Nucleic Acid Delivery: Lentiviral and Retroviral Vectors," Material Method, vol. 3, p. 174, 2013.
 T. C. He, S. B. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein, "A simplified system for generating recombinant adenoviruses," Proceedings of the National Academy of Sciences of the United States of America, vol. 95, pp. 2509-2514, 1998.
 E. Wagner, M. J. Hewlett, D. C. Bloom, and D. Camerini, "Basic Virology," Blackwell Publishing, 2008.
 J. S. Richard, "Adeno-associated virus: integration at a specific chromosomal locus.," Curr. Opin. Genet., vol. 3, pp. 74–80, 1993.
 H. Buning, L. Perabo, O. Coutelle, S. Quadt-Humme, and M. Hallek, "Recent developments in adeno-associated virus vector technology," Journal of Gene Medicine, vol. 10, pp. 717-733, 2008.
 H. Yin, R. L. Kanasty, A. A. Eltoukhy, A. J. Vegas, J. R. Dorkin, and D. G. Anderson, "Non-viral vectors for gene-based therapy," Nature Reviews Genetics, vol. 15, pp. 541-555, 2014.
 W. E. Klein RM, Wu R, Sanford JC., "High-velocity microprojectiles for delivering nucleic acids into living cells. Biotechnology.," Biotechnology, vol. 24, pp. 384-6, 1992.
 M. Uchida, H. Natsume, D. Kobayashi, K. Sugibayashi, and Y. Morimoto, "Effects of particle size, helium gas pressure and microparticle dose on the plasma concentration of indomethacin after bombardment of indomethacin-loaded poly-L-lactic acid microspheres using a Helios (TM) gun system," Biological & Pharmaceutical Bulletin, vol. 25, pp. 690-693, 2002.
 N. Yang, J. Burkholder, B. Roberts, B. Martinell, and D. McCabe, "In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment," Genetics, vol. 87, pp. 9568-9572, 1990.
 A. V. Titomirov, S. Sukharev, and E. Kistanova, "In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA," Biochimica Et Biophysica Acta, vol. 1088, pp. 131-134, 1991.
 F. Andre and L. M. Mir, "DNA electrotransfer: its principles and an updated review of its therapeutic applications," Gene Therapy, vol. 11, pp. S33-S42, 2004.
 G. ter Haar, "Therapeutic applications of ultrasound," Progress in Biophysics & Molecular Biology, vol. 93, pp. 111-129, 2007.
 H. J. Kim, J. F. Greenleaf, R. R. Kinnick, J. T. Bronk, and M. E. Bolander, "Ultrasound-mediated transfection of mammalian cells," Human Gene Therapy, vol. 7, pp. 1339-1346, 1996.
 P. George, P. Demetrios, and J. V. William, "Chapter 4 Lipid Vesicles as Carriers for Introducing Biologically Active Materials into Cells," Methods in Cell Biology, vol. 14, pp. 33–71, 1976.
 C. T. de Ilarduya, Y. Sun, and N. Duezguenes, "Gene delivery by lipoplexes and polyplexes," European Journal of Pharmaceutical Sciences, vol. 40, pp. 159-170, 2010.
 J. H. Felgner, R. Kumar, C. N. Sridhar, C. J. Wheeler, Y. J. Tsai, R. Border, P. Ramsey, M. Martin, and P. L. Felgner, "Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations," Journal of Biological Chemistry, vol. 269, pp. 2550-2561, 1994.
 P. L. Felgner, Ringold, G. M., "Cationic liposome-mediated transfection," Nature, vol. 337, pp. 387-388, 1989.
 C. F. Bennett, M. Y. Chiang, H. D. Chan, J. E. E. Shoemaker, and C. K. Mirabelli, "Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides," Molecular Pharmacology, vol. 41, pp. 1023-1033, 1992.
 C. Y. Wang, Huang, L., "Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes," Biochemistry, vol. 28, pp. 9508-9514, 1989.
 J. Y. Legendre and F. C. Szoka, "Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes," Pharmaceutical Research, vol. 9, pp. 1235-1242, 1992.
 X. H. Zhou and L. Huang, "DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action," Biochimica Et Biophysica Acta-Biomembranes, vol. 1189, pp. 195-203, 1994.
 Y. H. Xu and F. C. Szoka, "Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection," Biochemistry, vol. 35, pp. 5616-5623, 1996.
 T. B. Wyman, F. Nicol, O. Zelphati, P. V. Scaria, C. Plank, and F. C. J. Szoka, "Design, Synthesis, and Characterization of a Cationic Peptide That Binds to Nucleic Acids and Permeabilizes Bilayers," Biochemistry, vol. 36, pp. 3008-3017, 1996.
 E. Hellstrand, A. Nowacka, D. Topgaard, S. Linse, and E. Sparr, "Membrane Lipid Co-Aggregation with alpha-Synuclein Fibrils," Plos One, vol. 8, p. 10, 2013.
 A. V. Ulasov, Y. V. Khramtsov, G. A. Trusov, A. A. Rosenkranz, E. D. Sverdlov, and A. S. Sobolev, "Properties of PEI-based Polyplex Nanoparticles That Correlate With Their Transfection Efficacy," Molecular Therapy, vol. 19, pp. 103-112, 2011.
 D. T. Curiel, S. Agarwal, E. Wagner, and M. Cotten, "Adenovirus enhancement of transferrin-polylysine-mediated gene delivery," Proceedings of the National Academy of Sciences of the United States of America, vol. 88, pp. 8850-8854, 1991.
 L. Jin, X. Zeng, M. Liu, Y. Deng, and N. Y. He, "Current progress in gene delivery technology based on chemical methods and nano-carriers," Theranostics, vol. 4, pp. 240-255, 2014.
 Z. Pharma, "What are peptides."
Available from： dhttp://www.zealandpharma.com/research-and-development/key-zealand-peptide-competences/what-are-peptides
 M. Green and P. M. Loewenstein, "Autonomous functional domains of chemically synthesized human immunodeficiency virus tat activator protein," Cell, vol. 55, pp. 1179-1188, 1988.
 A. D. Frankel and C. O. Pabo, "Cellular uptake of the tat protein from human immunodeficiency virus," Cell, vol. 55, pp. 1189-1193, 1988.
 E. Vives, P. Brodin, and B. Lebleu, "A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus," Journal of Biological Chemistry, vol. 272, pp. 16010-16017, 1997.
 K. M. Wagstaff and D. A. Jans, "Protein transduction: Cell penetrating peptides and their therapeutic applications," Current Medicinal Chemistry, vol. 13, pp. 1371-1387, 2006.
 F. Madani, S. Lindberg, U. Langel, S. Futaki, and A. Gr¨slund, "Mechanisms of Cellular Uptake of Cell-Penetrating Peptides," Journal of Biophysics, vol. 2011, 2011.
 Y. W. Huang, H. J. Lee, L. M. Tolliver, and R. S. Aronstam, "Delivery of Nucleic Acids and Nanomaterials by Cell-Penetrating Peptides: Opportunities and Challenges," Biomed Research International, vol. 2015, p. 834079, 2015.
 J. Regberg, A. Srimanee, and Ü. Langel, "Applications of Cell-Penetrating Peptides for Tumor Targeting and Future Cancer Therapies," Pharmaceuticals, vol. 5, p. 991, 2012.
 W. Y. Li, Y. J. Liu, J. W. Du, K. F. Ren, and Y. X. Wang, "Cell penetrating peptide-based polyplexes shelled with polysaccharide to improve stability and gene transfection," Nanoscale, vol. 7, pp. 8476-8484, 2015.
 J. Hoyer and I. Neundorf, "Peptide Vectors for the Nonviral Delivery of Nucleic Acids," Accounts of Chemical Research, vol. 45, pp. 1048-1056, 2012.
 J. M. Gump and S. F. Dowdy, "TAT transduction: the molecular mechanism and therapeutic prospects," Trends in Molecular Medicine, vol. 13, pp. 443-448, 2007.
 B. R. Liu, Y.-w. Huang, J. G. Winiarz, H.-J. Chiang, and H.-J. Lee, "Intracellular delivery of quantum dots mediated by a histidine- and arginine-rich HR9 cell-penetrating peptide through the direct membrane translocation mechanism," Biomaterials, vol. 32, pp. 3520-3537, 2011.
 S. Futaki, T. Suzuki, W. Ohashi, T. Yagami, S. Tanaka, K. Ueda, and Y. Sugiura, "Arginine-rich peptides - An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery," Journal of Biological Chemistry, vol. 276, pp. 5836-5840, 2001.
 J. L. Zaro and W. C. Shen, "Quantitative comparison of membrane transduction and endocytosis of oligopeptides," Biochemical and Biophysical Research Communications, vol. 307, pp. 241-247, 2003.
 A. F. Saleh, H. Aojula, Y. Arthanari, S. Offerman, M. Alkotaji, and A. Pluen, "Improved Tat-mediated plasmid DNA transfer by fusion to LK15 peptide," Journal of Controlled Release, vol. 143, pp. 233-242, 2010.
 F. Salomone, F. Cardarelli, M. Di Luca, C. Boccardi, R. Nifosi, G. Bardi, L. Di Bari, M. Serresi, and F. Beltram, "A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape," J Control Release, vol. 163, pp. 293-303, 2012.
 Y. J. Lee, A. Erazo-Oliveras, and J. P. Pellois, "Delivery of Macromolecules into Live Cells by Simple Co-incubation with a Peptide," Chembiochem, vol. 11, pp. 325-330, 2010.
 L. K. Fei, L. Ren, J. L. Zaro, and W. C. Shen, "The influence of net charge and charge distribution on cellular uptake and cytosolic localization of arginine-rich peptides," Journal of Drug Targeting, vol. 19, pp. 675-680, 2011.
 S. Abes, J. J. Turner, G. D. Ivanova, D. Owen, D. Williams, A. Arzumanov, P. Clair, M. J. Gait, and B. Lebleu, "Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide (vol 35, pg 4495, 2007)," Nucleic Acids Research, vol. 35, pp. 7396-7396, 2007.
 S. Deshayes, K. Konate, A. Rydstrom, L. Crombez, C. Godefroy, P. E. Milhiet, A. Thomas, R. Brasseur, G. Aldrian, F. Heitz, M. A. Munoz-Morris, J. M. Devoisselle, and G. Divita, "Self-assembling peptide-based nanoparticles for siRNA delivery in primary cell lines," Small, vol. 8, pp. 2184-2188, 2012.
 J.-M. Crowet, L. Lins, S. Deshayes, G. Divita, M. Morris, R. Brasseur, and A. Thomas, "Modeling of non-covalent complexes of the cell-penetrating peptide CADY and its siRNA cargo," Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1828, pp. 499-509, 2013.
 R. H. Mo, J. L. Zaro, and W. C. Shen, "Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy," Mol Pharm, vol. 9, pp. 299-309, 2012.
 H. L. Amand, B. Norden, and K. Fant, "Functionalization with C-terminal cysteine enhances transfection efficiency of cell-penetrating peptides through dimer formation," Biochemical and Biophysical Research Communications, vol. 418, pp. 469-474, 2012.
 M. Balakirev, G. Schoehn, and J. Chroboczek, "Lipoic acid-derived amphiphiles for redox-controlled DNA delivery," Chemistry & Biology, vol. 7, pp. 813-819, 2000.
 M. L. Read, K. H. Bremner, D. Oupicky, N. K. Green, P. F. Searle, and L. W. Seymour, "Vectors based on reducible polycations facilitate intracellular release of nucleic acids," Journal of Gene Medicine, vol. 5, pp. 232-245, 2003.
 O. Boussif, F. Lezoualch, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, and J. P. Behr, "A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.," Proceedings of the National Academy of Sciences of the United States of America, vol. 92, pp. 7297-7301, 1995.
 L. De Laporte, J. C. Rea, and L. D. Shea, "Design of modular non-viral gene therapy vectors," Biomaterials, vol. 27, pp. 947-954, 2006.
 D. Fischer, T. Bieber, Y. X. Li, H. P. Elsasser, and T. Kissel, "A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection efficiency and cytotoxicity," Pharmaceutical Research, vol. 16, pp. 1273-1279, 1999.
 C. N. Lungu, M. V. Diudea, M. V. Putz, and I. P. Grudzinski, "Linear and Branched PEIs (Polyethylenimines) and Their Property Space," International Journal of Molecular Sciences, vol. 17, p. 12, 2016.
 Z. Y. Zhang and B. D. Smith, "High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: Membrane bending model," Bioconjugate Chemistry, vol. 11, pp. 805-814, 2000.
 A. E. Nel, L. Madler, D. Velegol, T. Xia, E. M. V. Hoek, P. Somasundaran, F. Klaessig, V. Castranova, and M. Thompson, "Understanding biophysicochemical interactions at the nano-bio interface," Nature Materials, vol. 8, pp. 543-557, 2009.
 E. J. Kwon, S. Liong, and S. H. Pun, "A truncated HGP peptide sequence that retains endosomolytic activity and improves gene delivery efficiencies," Mol Pharm, vol. 7, pp. 1260-5, 2010.
 H. J. Lee, R. Namgung, W. J. Kim, J. I. Kim, and I.-K. Park, "Targeted delivery of microRNA-145 to metastatic breast cancer by peptide conjugated branched PEI gene carrier," Macromolecular Research, vol. 21, pp. 1201-1209, 2013.
 S. Yamano, J. Dai, S. Hanatani, K. Haku, T. Yamanaka, M. Ishioka, T. Takayama, C. Yuvienco, S. Khapli, A. M. Moursi, and J. K. Montclare, "Long-term efficient gene delivery using polyethylenimine with modified Tat peptide," Biomaterials, vol. 35, pp. 1705-1715, 2014.
 Y. M. Lee, D. Lee, J. Kim, H. Park, and W. J. Kim, "RPM peptide conjugated bioreducible polyethylenimine targeting invasive colon cancer," J Control Release, vol. 205, pp. 172-80, 2015.
 T. Zhang, X. Xue, D. He, and J. T. Hsieh, "A prostate cancer-targeted polyarginine-disulfide linked PEI nanocarrier for delivery of microRNA," Cancer Letters, vol. 365, pp. 156-165, 2015.
 J. S. Oh, M. Park, J. S. Kim, and J. H. Jang, "Enhanced Cellular Transfection by Ternary Non-Viral Gene Vectors Coupled with Adeno-Associated Virus-Derived Peptides," Macromolecular Bioscience, vol. 14, pp. 121-130, 2014.
 E. B. Getz, M. Xiao, T. Chakrabarty, R. Cooke, and P. R. Selvin, "A comparison between the sulfhydryl reductants tris(2-carboxyethyl)phosphine and dithiothreitol for use in protein biochemistry," Anal Biochem, vol. 273, pp. 73-80, 1999.
 Tania, "TCEP or DTT?," 2014.
Available from： http://sites.psu.edu/msproteomics/2014/05/30/tcep-or-dtt/
 P. Cayot and G. Tainturier, "The quantification of protein amino groups by the trinitrobenzenesulfonic acid method: a reexamination," Anal Biochem, vol. 249, pp. 184-200, 1997.
 Y. Kang, S. Semones, J. Smith, and M. Frodyma, "Bacillus amyloliquefaciens strain," ed: Google Patents, 2011.
 I. Yudovin-Farber, J. Golenser, N. Beyth, E. I. Weiss, and A. J. Domb, "Quaternary Ammonium Polyethyleneimine: Antibacterial Activity," Journal of Nanomaterials, 2010.
 Edgar, " Chemical reaction of Ellman′s reagent (5,5′-dithiobis-(2-nitrobenzoic acid) or DTNB) with a thiol," 2010.
Available from： http://sites.psu.edu/msproteomics/2014/05/30/tcep-or-dtt/
X. J. Loh, T. C. Lee, Q. Dou, and G. R. Deen, "Utilising inorganic nanocarriers for gene delivery," Biomater Sci, vol. 4, pp. 70-86, 2016.
 R. Kircheis, L. Wightman, and E. Wagner, "Design and gene delivery activity of modified polyethylenimines," Advanced Drug Delivery Reviews, vol. 53, pp. 341-358, 2001.
 W. Zauner, N. A. Farrow, and A. M. Haines, "In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density," J Control Release, vol. 71, pp. 39-51, 2001.
 T. R. Green, J. Fisher, M. Stone, B. M. Wroblewski, and E. Ingham, "Polyethylene particles of a ′critical size′ are necessary for the induction of cytokines by macrophages in vitro," Biomaterials, vol. 19, pp. 2297-302, 1998.
 S. P. Strand, S. Danielsen, B. E. Christensen, and K. M. Varum, "Influence of chitosan structure on the formation and stability of DNA-chitosan polyelectrolyte complexes," Biomacromolecules, vol. 6, pp. 3357-3366, 2005.
 N. Jain, V. Goldschmidt, S. Oncul, Y. Arntz, G. Duportail, Y. Mély, and A. Klymchenko, "Lactose-ornithine bolaamphiphiles for efficient gene delivery in vitro," International Journal of Pharmaceutics, vol. 423, pp. 392-400, 2012.
 Y. Liu, D. A. Peterson, H. Kimura, and D. Schubert, "Mechanism of Cellular 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) Reduction," Journal of Neurochemistry, vol. 69, pp. 581-593, 1997.
 F. Simeoni, M. C. Morris, F. Heitz, and G. Divita, "Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells," Nucleic Acids Research, vol. 31, pp. 2717-2724, 2003.
 R. Pan, W. Xu, F. Yuan, D. Chu, Y. Ding, B. Chen, M. Jafari, Y. Yuan, and P. Chen, "A novel peptide for efficient siRNA delivery in vitro and therapeutics in vivo," Acta Biomaterialia, vol. 21, pp. 74-84, 2015.
 A. Anna, D. Catherine, D. Géraldine, L. C. Eric, M. Claude, T. François, and B. Jean-Rémi, "Influence of the Internalization Pathway on the Efficacy of siRNA Delivery by Cationic Fluorescent Nanodiamonds in the Ewing Sarcoma Cell Model," Plos One, vol. 7, p. e52207, 2012.